Cargando…

Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro)

The emerging SARS-CoV-2 infection is the cause of the global COVID-19 pandemic. To date, there are limited therapeutic options available to fight this disease. Here we examined the inhibitory abilities of two broad-spectrum antiviral natural products chebulagic acid (CHLA) and punicalagin (PUG) agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Ruikun, Cooper, Laura, Chen, Zinuo, Lee, Hyun, Rong, Lijun, Cui, Qinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052511/ https://www.ncbi.nlm.nih.gov/pubmed/33872675 http://dx.doi.org/10.1016/j.antiviral.2021.105075

Ejemplares similares

Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors
por: Li, Ping, et al.
Publicado: (2020)

Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry
por: Lin, Liang-Tzung, et al.
Publicado: (2013)

Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
por: Chen, Zinuo, et al.
Publicado: (2021)

SARS-CoV-2 cell entry and targeted antiviral development
por: Chen, Zinuo, et al.
Publicado: (2021)

Revisiting influenza A virus life cycle from a perspective of genome balance
por: Du, Ruikun, et al.
Publicado: (2022)

A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus
por: Zhao, Xiujuan, et al.
Publicado: (2019)

Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro
por: Lu, Lian, et al.
Publicado: (2022)

Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy
por: Zhao, Xiujuan, et al.
Publicado: (2022)

Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor
por: Athira, A. P., et al.
Publicado: (2013)

Small Molecule Inhibitors of Influenza Virus Entry
por: Chen, Zhaoyu, et al.
Publicado: (2021)

Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019)

Flu Universal Vaccines: New Tricks on an Old Virus
por: Du, Ruikun, et al.
Publicado: (2020)

Anti-Hyperglycemic Effect of Chebulagic Acid from the Fruits of Terminalia chebula Retz
por: Huang, Yi-Na, et al.
Publicado: (2012)

Lignans and Their Derivatives from Plants as Antivirals
por: Cui, Qinghua, et al.
Publicado: (2020)

The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2
por: Chen, Hsiao-Fan, et al.
Publicado: (2023)

Physiological and Immune Functions of Punicalagin
por: Venusova, Eva, et al.
Publicado: (2021)

Neuroprotective Effect of Chebulagic Acid via Autophagy Induction in SH-SY5Y Cells
por: Kim, Hee Ju, et al.
Publicado: (2014)

Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
por: Cui, Qinghua, et al.
Publicado: (2018)

Punicalagin Targets Atherosclerosis: Gene Expression Profiling of THP-1 Macrophages Treated with Punicalagin and Molecular Docking
por: Huwait, Etimad, et al.
Publicado: (2022)

Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CL(pro) inhibitors for treating COVID-19
por: Zhang, Jian-Wei, et al.
Publicado: (2022)

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
por: Zhao, Jing, et al.
Publicado: (2023)

Discovery of Small-Molecule Allosteric Inhibitors of PfATC as Antimalarials
por: Wang, Chao, et al.
Publicado: (2022)

Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus
por: Duncan, Maggie C., et al.
Publicado: (2020)

Transcriptomic analysis of Bursaphelenchus xylophilus treated by a potential phytonematicide, punicalagin
por: Guo, Qun-Qun, et al.
Publicado: (2020)

Ferroptosis-Inhibitory Difference between Chebulagic Acid and Chebulinic Acid Indicates Beneficial Role of HHDP
por: Yang, Lin, et al.
Publicado: (2021)

Pyrogallol, Corilagin and Chebulagic acid target the “fuzzy coat” of alpha-synuclein to inhibit the fibrillization of the protein
por: Bopardikar, Mandar, et al.
Publicado: (2022)

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

Allosteric inhibition of SARS-CoV-2 3CL protease by colloidal bismuth subcitrate
por: Tao, Xuan, et al.
Publicado: (2021)

Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
por: Cui, Qinghua, et al.
Publicado: (2018)

Discovery of SARS-CoV-2 3CL(Pro) Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions
por: Wang, Yaxin, et al.
Publicado: (2022)

Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids
por: Kesharwani, Ajay, et al.
Publicado: (2017)

Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants
por: Jukič, Marko, et al.
Publicado: (2021)

Punicalagin in Cancer Prevention—Via Signaling Pathways Targeting
por: Berdowska, Izabela, et al.
Publicado: (2021)

Antibiofilm effects of punicalagin against Staphylococcus aureus in vitro
por: Xu, Yunfeng, et al.
Publicado: (2023)

Chebulagic Acid, a Hydrolyzable Tannin, Exhibited Antiviral Activity in Vitro and in Vivo against Human Enterovirus 71
por: Yang, Yajun, et al.
Publicado: (2013)

Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase
por: Wang, Lin, et al.
Publicado: (2019)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL(pro) from Ginkgo biloba leaves via large-scale screening
por: Xiong, Yuan, et al.
Publicado: (2021)

Discovery and characterization of the covalent SARS-CoV-2 3CL(pro) inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
por: Zhang, Ya-Ni, et al.
Publicado: (2023)

In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
por: Maulana, Saipul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_86ql2f0t2go3enna4ctvd51ftu